Korro Bio, Inc. - Schedule 13G Filing

This filing details the beneficial ownership of Korro Bio, Inc. common stock by several entities and individuals, collectively referred to as the Reporting Persons. The primary holders include Venrock Healthcare Capital Partners III, L.P. (VHCP III), VHCP Co-Investment Holdings III, LLC, and Venrock Healthcare Capital Partners EG, L.P. (VHCP EG), along with their management entities and key individuals Nimish Shah and Bong Koh. As of March 10, 2026, the Reporting Persons collectively beneficially own 1,488,685 shares of common stock, representing 9.9% ownership. This ownership is derived from shares of common stock and pre-funded warrants. A beneficial ownership blocker provision within the pre-funded warrants restricts the exercise of these warrants to prevent beneficial ownership from exceeding 9.99% of the outstanding common stock. The filing includes joint filing agreements and powers of attorney authorizing representatives to act on behalf of the Reporting Persons.